Suddenly, Cannabis Science, Inc. (OTC:CBIS) jumped on the massive trade. Yesterday, the stock soared 21.05% and 
managed to trade over 31 million shares on the market.
Following the recent news by Cannabis, the huge gain looks easy to be explained. Just yesterday, the company issued Sales Guidance and Outlook for 2012. According to it, the company’s sales for the next year are forecasted at $6,846,000 with a potential increase to $65,740,000 in 2014 and $0.02 per share positive earnings.
The earnings projections immediately pumped up CBIS stock price, though it is still not certain how long the climb will resist.
When looking back to mid-December, CBIS has had surprisingly high volume. However, it was due to another positive announcement by Cannabis, accompanied by promotions at that time.
Meanwhile, the company’s financials haven’t improved at all. The latest 10-Q states: $6.2 thousand in cash, $70 thousand total assets, and $2.1 million total current liabilities.[BANNER]
On top of the bad financials, CBIS has been diluting its stock in huge proportions. At the beginning of the year, the OS was approximately 101 million shares; as of Nov. 4 it was close to 242 million.
Obviously, apart from optimistic projections, Cannabis has nothing else to share with investors at this point.
